Chronic central serous chorioretinopathy
Showing 1 - 25 of >10,000
Central Serous Chorioretinopathy Trial in Bordeaux (micropulse laser)
Not yet recruiting
- Central Serous Chorioretinopathy
- micropulse laser
-
Bordeaux, FranceCHU Bordeaux
Jan 9, 2023
Chronic Central Serous Chorioretinopathy Trial in Nijmegen, Rotterdam (steroid eye drops, Placebo)
Not yet recruiting
- Chronic Central Serous Chorioretinopathy
- steroid eye drops
- Placebo
-
Nijmegen, Netherlands
- +1 more
Nov 21, 2022
Central Serous Chorioretinopathy Trial (100µm laser spot diameter micropulse laser, 200µm laser spot diameter micropulse laser)
Not yet recruiting
- Central Serous Chorioretinopathy
- 100μm laser spot diameter micropulse laser
- 200μm laser spot diameter micropulse laser
- (no location specified)
Jan 13, 2023
Choroidal Blood Flow in Acute and Chronic Central Serous
Recruiting
- Central Serous Chorioretinopathy
-
Stavanger, NorwayStavanger University Hospital, Department of Ophthalmology
Oct 18, 2022
Central Serous Chorioretinopathy, Therapy, Photodynamic Trial in Beijing (50% dose of photodynamic therapy, 70% dose of
Recruiting
- Central Serous Chorioretinopathy
- Therapy, Photodynamic
- 50% dose of photodynamic therapy
- 70% dose of photodynamic therapy
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 21, 2022
Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta
Completed
- Central Serous Chorioretinopathy
- Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy
-
Cairo, EgyptKasr alainy faculty of medicine
May 5, 2023
Central Serous Chorioretinopathy Trial in Hong Kong
Recruiting
- Central Serous Chorioretinopathy
-
Hong Kong, Hong Kong
- +2 more
Apr 19, 2022
Acute Central Serous Retinopathy With Subretinal Fluid Trial in Minya (Micropulse laser)
Completed
- Acute Central Serous Retinopathy With Subretinal Fluid
- Micropulse laser
-
Minya, Minia, EgyptMinia University Hospital
Sep 8, 2022
Central Serous Chorioretinopathy Trial in East Melbourne, Glen Iris (2RT subthreshold nanosecond laser - active, 2RT
Recruiting
- Central Serous Chorioretinopathy
- 2RT subthreshold nanosecond laser - active
- 2RT subthreshold nanosecond laser - sham
-
East Melbourne, Victoria, Australia
- +1 more
Oct 17, 2022
Acute Central Serous Chorioretinopathy Trial in Guangzhou (577-MPL, HD-PDT)
Completed
- Acute Central Serous Chorioretinopathy
- 577-MPL
- HD-PDT
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Apr 4, 2022
Central Serous Chorioretinopathy, Chronic Central Serous Chorioretinopathy Trial in Ankara (Source of growth factors: autologous
Completed
- Central Serous Chorioretinopathy
- Chronic Central Serous Chorioretinopathy
- Source of growth factors: autologous platelet-rich plasma (aPRP) + repetitive electromagnetic stimulation for iontophoresis
-
Ankara, Türkiye, TurkeyAnkara University Biotechnology Institute
Jan 9, 2020
Eplerenone Versus PDT: Comparative Study by OCTA
Completed
- Central Serous Chorioretinopathy
- Eplerenone
- The patients underwent half fluence photodynamic therapy for 6 months
- (no location specified)
Oct 21, 2021
Chorioretinopathy, Central Serous Trial in Shiraz (Crocin, Placebo)
Recruiting
- Chorioretinopathy, Central Serous
- Crocin
- Placebo
-
Shiraz, Fars, Iran, Islamic Republic ofShiraz University of Medical Sciences
Oct 27, 2021
Chronic Central Serous Chorioretinopathy Trial in Amsterdam, Leiden, Nijmegen (Eplerenone, Photodynamic therapy)
Unknown status
- Chronic Central Serous Chorioretinopathy
- Eplerenone
- Photodynamic therapy
-
Amsterdam, Netherlands
- +2 more
Oct 22, 2019
Age-Related Macular Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy Trial in New York (OCT Imaging Using
Not yet recruiting
- Age-Related Macular Degeneration
- +5 more
- OCT Imaging Using Device N
- OCT Imaging Using Device C
-
New York, New YorkNYU Langone Health
Jan 6, 2023
Choroidal Ischemia, Vitelliform Macular Dystrophy, Age-related Macular Degeneration Trial in New York (drug, other, diagnostic
Recruiting
- Choroidal Ischemia
- +4 more
- Sildenafil
- +3 more
-
New York, New YorkColumbia University Medical Center, Edward Harkness Eye Institut
May 2, 2022
Central Serous Chorioretinopathy, Irvine-Gass Syndrome, Pars Planitis Trial in Banha (Triamcinolone Acetonide)
Recruiting
- Central Serous Chorioretinopathy
- +3 more
- Triamcinolone Acetonide
-
Banhā, QA, EgyptAhmed Abdelshafy
Apr 13, 2022
Association Between CRSA and OSA
Recruiting
- Chorioretinopathy
- Obstructive Sleep Apnea
-
Poitiers, FranceCHU de Poitiers
Apr 13, 2021
OCT in Rare Chorioretinal Diseases
Recruiting
- Retinal Artery Occlusions
- +4 more
-
Portland, OregonCasey Eye Institute, Oregon Health & Science University
Jul 13, 2021
Multiple Eye Fundus Diseases From Color Fundus Photograph
Completed
- Diabetic Retinopathy
- +12 more
- Software assisted imaging diagnosis
-
BeiJing, Beijing, China
- +4 more
Dec 28, 2021
Central Serous Chorioretinopathy, Age Related Macular Degeneration, Idiopathic Poplypoidal Choroidal Vasculopathy Trial in
Recruiting
- Central Serous Chorioretinopathy
- +2 more
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jan 25, 2021
Pilot Study on Deep Learning in the Eye
Not yet recruiting
- Central Serous Chorioretinopathy
- +2 more
- Image classification using deep learning algorithm
- (no location specified)
Jan 5, 2021
Central Serous Chorioretinopathy Trial in Besançon (RTX1 IMAGIN EYE retinal camera)
Terminated
- Central Serous Chorioretinopathy
- RTX1 IMAGIN EYE retinal camera
-
Besançon, FranceCHU Besançon
Sep 13, 2019
Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)
Completed
- Retinitis Pigmentosa
- Wharton's jelly derived mesenchymal stemcells
- Magnovision
-
Ankara, Gölbaşı, Turkey
- +2 more
Mar 23, 2023
Central Serous Chorioretinopathy Trial in Buenos Aires, Tel Aviv (Brinzolamide Ophthalmic)
Unknown status
- Central Serous Chorioretinopathy
- Brinzolamide Ophthalmic
-
Buenos Aires, Argentina
- +1 more
May 29, 2018